| EGb 761® (N = 18) | Placebo (N = 18) | p-Value* |
Patient’s global rating of severity (VAS, 0 - 100) |
|
| |
change at day 120 | −17.8 (−26.7; −8.8) | −3.9 (−15.0; 7.2) | 0.012** |
change at day 180 | −20.4 (−30.7; −10.1) | −6.8 (−18.0; 4.4) | 0.04 |
Physician’s global rating of change# |
|
|
|
at day 120 | 3.0 (2.5; 3.5) | 3.2 (2.6; 3.8) | 0.31# |
at day 180 | 2.6 (2.1; 3.1) | 3.2 (2.6; 3.7) | 0.19 |
Vertigo score |
|
|
|
change at day 120 | −7.3 (−11.5; −3.0) | −2.9 (−5.2; −0.6) | 0.14 |
change at day 180 | −7.8 (−12.4; −3.1) | −2.7 (−5.0; −0.4) | 0.04 |